BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11848724)

  • 1. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
    Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
    Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
    Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
    Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Lung function and death from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes.
    Ann Intern Med; 2002 Feb; 136(4):I35. PubMed ID: 11848738
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
    Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
    Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.
    Hersh CP; Dahl M; Ly NP; Berkey CS; Nordestgaard BG; Silverman EK
    Thorax; 2004 Oct; 59(10):843-9. PubMed ID: 15454649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
    Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
    Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
    Dahl M; Tybjaerg-Hansen A; Lange P; Nordestgaard BG
    Respir Res; 2005 Oct; 6(1):113. PubMed ID: 16212675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
    Ghosh AJ; Hobbs BD; Moll M; Saferali A; Boueiz A; Yun JH; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner G; Brown KK; Wise R; Martinez FJ; Lomas D; Castaldi PJ; Carey VJ; DeMeo DL; Cho MH; Silverman EK; Hersh CP;
    Am J Respir Crit Care Med; 2022 Feb; 205(3):313-323. PubMed ID: 34762809
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study.
    Dahl M; Tybjaerg-Hansen A; Sillesen H; Jensen G; Steffensen R; Nordestgaard BG
    Circulation; 2003 Feb; 107(5):747-52. PubMed ID: 12578879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
    Franciosi AN; Carroll TP; McElvaney NG
    Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
    Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
    Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.
    North TL; Ben-Shlomo Y; Cooper C; Deary IJ; Gallacher J; Kivimaki M; Kumari M; Martin RM; Pattie A; Sayer AA; Starr JM; Wong A; Kuh D; Rodriguez S; Day IN
    J Med Genet; 2016 Apr; 53(4):280-8. PubMed ID: 26831755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Rare
    Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
    Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
    Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
    Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.
    Silverman EK
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S341-5. PubMed ID: 27564671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.
    Castaldi PJ; DeMeo DL; Kent DM; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Griffith JL; Silverman EK
    Am J Epidemiol; 2009 Oct; 170(8):1005-13. PubMed ID: 19726494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
    Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
    Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
    Al Ashry HS; Strange C
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.